We provide DNA extraction services for a wide variety of sample types including blood, tissue, and cells. This is a complimentary service included with all sequencing projects.
With +15 years in the industry, The Sequencing Center’s CEO, Richard Casey Ph.D, has long believed that the future of biological and medical discoveries will be driven by genomics. After years of watching fellow colleagues struggle to get critical genomic data for their research, he decided it was time to solve this problem in the commercial business realm. He envisioned a world where genome sequencing would be an effortless and efficient process at prices that wouldn’t decimate grant funding or take months to receive data.
“Let researchers focus on discovery and innovation. Leave the lab work to us.”
– Richard Casey PhD, CEO of The Sequencing Center
While most companies have a focus on centerpiece research, our facility focuses on efficiency in the edges, enabling our customers to rely on a single facility for their end-to-end research. We saw conventional lab methodologies failing to make sequencing more accessible to researchers, so we put together team to reinvent the sequencing lab model with a hyper efficient, top-quality sequencing operation supported by automation.
All-Inclusive Lab Services
We use industry-standard preparation kits from Illumina, Nanopore, GenDX, Pillar Biosciences to create a high quality sequencing library. Samples undergo multiple QC checks to ensure they meet the kit expectations throughout preparation.
All projects are delivered with both the raw fastQ data files as well as corresponding variant alignment, HLA tying, or other gene panel-specific reports.
The Sequencing Center is a USA-owned and operated next-generation genome sequencing company offering affordable genome sequencing and bioinformatics for research, pharmaceutical, and clinical organizations. Our services are designed for organizations performing research on bacterial, viral, and human-oriented research. Among these services, our facility offers targeted sequencing methods for research fields including inherited diseases, oncology, neurodegenerative diseases, antibiotic-resistant gene analysis, and biomarker discovery for drug development optimization.